Multiplier AI Blog
Know How Data, AI, & Digital Marketing Can Help Pharma & Life Sciences
AI in Pharma Commercial Strategy: The Complete Guide to Omnichannel, Intelligence, and Execution
For years, pharma commercial teams were described as conservative, campaign-led, and slow to change. That view no longer reflects the reality of the market. Healthcare professionals now move across digital, field, scientific, peer-led, and mobile touchpoints every day.
Building an AI-First Pharma Commercial Engine: From Data to Decision in Real Time
Many pharma companies today claim to be using AI. They have dashboards, predictive models, automation tools, and analytics platforms. On paper, it appears that AI has been integrated into their operations.
The Future of AI in Pharma Engagement: What Will Change Between 2026 and 2030
Over the last decade, pharma has gradually adopted digital tools to improve engagement. Email campaigns became more targeted. CRM systems became more sophisticated. Omnichannel strategies emerged to coordinate touchpoints, and AI began to assist with analytics and content generation.
AI Governance Framework for Pharma: How to Control, Scale, and Trust AI Systems
AI is no longer a side experiment inside pharma companies. It is now entering commercial operations, medical affairs, regulatory workflows, content creation, HCP engagement, competitive intelligence, field planning, and analytics.
Ethical AI in Pharma Engagement: Building Trust While Scaling Intelligence
AI is rapidly becoming a core part of how pharma organizations operate. It influences how data is analyzed, how content is generated, how HCPs are prioritized, and how engagement strategies are executed.
Data Privacy in Omnichannel Pharma Engagement: What You Must Get Right
Pharma engagement has entered a new phase where data sits at the center of every meaningful interaction. Understanding how healthcare professionals engage, what content they consume, when they respond, and how their preferences evolve is now essential for delivering relevant communication.
AI in Pharma Compliance: How to Scale Personalization Without Breaking the Rules
Pharma is entering a phase where personalization is no longer optional. Healthcare professionals expect communication that reflects their interests, their patients, and their context. Generic messaging is increasingly ignored. Engagement quality is now directly tied to relevance.
Using Patent and Regulatory Filing Data to Predict Competitor Moves Before They Reach the Market
Most pharma teams believe they are monitoring competitors closely. They track launches, analyze prescribing trends, review conference data, and listen to field feedback. All of this is important, but it focuses on what is already visible.
What to Do When a Competitor Launches in Your Therapeutic Area: A 30-Day AI-Powered Response Playbook
A competitor launch is one of those moments that exposes how prepared a pharma organization really is. Before the launch, every team says they are watching the market closely. Commercial leaders believe they have the right visibility. Field teams believe they know their accounts. Brand teams believe their message is clear.
Competitive Share of Voice in Pharma: How AI Tracks It Across Digital and Field Channels
Competitive share of voice pharma AI tracking starts from a simple observation: in pharma, market share is often treated as the ultimate measure of success because it reflects prescribing behavior, adoption rates, and commercial performance. However, market share is an outcome.
How AI Summarizes Clinical Conference Insights for Pharma Field Teams
AI clinical conference insights in pharma address one of the industry's most persistent operational gaps. Clinical conferences are among the most information-rich events in the pharma industry — they bring together new research, expert opinions, emerging data, and evolving treatment perspectives in one place.
Turning Prescribing Pattern Shifts Into Field Intelligence: A Practical Guide
Every pharma organization has access to prescribing data. It is one of the most valuable assets in commercial operations. It shows what doctors are doing, how treatments are being adopted, and how markets are evolving.